BioScience Managers
As an international healthcare investment firm that finances and enables innovative science and technology with the potential to transform healthcare, we have a team with the ambition and experience to deliver impressive investment returns.
Latest news
- MIP Diagnostic Synthetic antibody offers ultra-high sensitivity for next wave of COVID-19 sensors 22 April 2021
- Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis expansion in Asia 13 April 2021
- Congenica Appoints Jayesh Pankhania as Chief Financial Officer 6 April 2021